Objetivos del control metabólico en la paciente con diabetes mellitus gestacional para prevención de la morbilidad fetal
ABSTRACT Gestational diabetes mellitus (GDM) is associated with maternal and fetal morbidity, which has been related to maternal glycemia. Various reports indicate that intensive therapy of GDM decreases the risk of perinatal morbidity. Self-monitoring of blood glucose (SMBG) provides crucial information in guiding therapy. In recent workshops and conferences on GDM, metabolic goals were lowered to those approaching the normal range. Currently recommended levels of maternal capillary blood glucose are ≤ 95 mg/dl in the fasting state, ≤ 140 mg/dl at 1 hour and/or ≤ 120 mg/dl at 2 hours after meals or even lower. However, surveys evaluating current clinical practice have described wide variations in adherence to these recommendations for SMBG, as well as in the metabolic control goals. In addition, the use of fetal measurements to guide metabolic control has been proposed.